Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

|Videos|November 18, 2022

Urology residency program director highlights key aspects he values in applicants

Author(s)Urology Times staff

Moben Mirza, MD, FACS, Residency Program Director and Professor, Department of Urology, University of Kansas, highlights the 3 top aspects he is looking for in a residency applicant.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

stethoscope sitting on a stack of books

Small urology programs saw increase in at-home, in-section matches during COVID-19 pandemic

ByHannah Clarke

March 24th 2023

mentor teaching two medical students

Dr. Litwin describes the challenges to a successful mentor/mentee relationship in urology

ByUrology Times staff

January 30th 2023

young female doctor standing in front of medical staff

Expert provides insight as to what makes a successful mentee

ByUrology Times staff

January 24th 2023

Dr. Litwin in an interview with Urology Times

Dr. Litwin shares ways to be an effective mentor

ByUrology Times staff

January 23rd 2023

Applications now open for Prospect: A paid summer medical student research fellowship in urology

ByHannah Clarke

December 16th 2022

Latest CME

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Jason Hafron, MD; Aaron D. Berger, MD; Arpeet Shah, MD

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Radioligand Therapy 101: The Science Behind the Strategy

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC

Individualizing androgen pathway therapy in mCSPC

Testosterone deficiency: FAQs from the AUA guideline

Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer

Cretostimogene Grenadenorepvec: Mechanism and Rationale